Department of Clinical Radiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, A16, 49149, Muenster, Germany.
iThera Medical, Munich, Germany.
Eur Radiol. 2018 Feb;28(2):602-609. doi: 10.1007/s00330-017-5002-x. Epub 2017 Aug 7.
Multispectral optoacoustic tomography (MSOT) represents a new in vivo imaging technique with high resolution (~250 μm) and tissue penetration (>1 cm) using the photoacoustic effect. While ultrasound contains anatomical information for lesion detection, MSOT provides functional information based on intrinsic tissue chromophores. We aimed to evaluate the feasibility of combined ultrasound/MSOT imaging of breast cancer in patients compared to healthy volunteers.
Imaging was performed using a handheld MSOT system for clinical use in healthy volunteers (n = 6) and representative patients with histologically confirmed invasive breast carcinoma (n = 5) and ductal carcinoma in situ (DCIS, n = 2). MSOT values for haemoglobin and oxygen saturation were assessed at 0.5, 1.0 and 1.5 cm depth and selected wavelengths between 700 and 850 nm.
Reproducible signals were obtained in all wavelengths with consistent MSOT signals in superficial tissue in breasts of healthy individuals. In contrast, we found increased signals for haemoglobin in invasive carcinoma, suggesting a higher perfusion of the tumour and tumour environment. For DCIS, MSOT values showed only little variation compared to healthy tissue.
This preliminary MSOT breast imaging study provided stable, reproducible data on tissue composition and physiological properties, potentially enabling differentiation of solid malignant and healthy tissue.
• A handheld MSOT probe enables real-time molecular imaging of the breast. • MSOT of healthy controls provides a reproducible reference for pathology identification. • MSOT parameters allows for differentiation of invasive carcinoma and healthy tissue.
多光谱光声断层扫描(MSOT)代表了一种新的体内成像技术,利用光声效应具有高分辨率(约 250μm)和组织穿透深度(>1cm)。虽然超声包含用于检测病变的解剖学信息,但 MSOT 基于固有组织发色团提供功能信息。我们旨在评估与健康志愿者相比,联合使用超声/MSOT 对乳腺癌患者进行成像的可行性。
使用手持式 MSOT 系统对健康志愿者(n=6)和经组织学证实的浸润性乳腺癌(n=5)和导管原位癌(DCIS,n=2)患者进行代表性成像。在 0.5、1.0 和 1.5cm 深度和 700 至 850nm 之间的选定波长处评估血红蛋白和氧饱和度的 MSOT 值。
在所有波长下均获得了可重复的信号,在健康个体乳房的浅层组织中具有一致的 MSOT 信号。相比之下,我们在浸润性癌中发现了血红蛋白信号增加,这表明肿瘤和肿瘤环境的灌注增加。对于 DCIS,与健康组织相比,MSOT 值仅略有变化。
这项初步的 MSOT 乳房成像研究提供了关于组织成分和生理特性的稳定、可重复的数据,可能能够区分实体恶性和健康组织。
手持式 MSOT 探头能够实时对乳房进行分子成像。
健康对照组的 MSOT 提供了病理识别的可重复参考。
MSOT 参数允许区分浸润性癌和健康组织。